Search - tctmd.com

Displaying 581 - 600 of 1027

Sort: Relevancy | Date

News Conference News ACC 2014

No Impact on Safety Seen at Hospitals Performing PCI with No Surgical Backup

L.A. McKeown

March 30, 2014

News Conference News ACC 2014

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

L.A. McKeown

March 30, 2014

News Conference News ACC 2014

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

L.A. McKeown

March 30, 2014

News Conference News ACC 2014

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

L.A. McKeown

March 29, 2014

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

News Daily News

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

L.A. McKeown

March 27, 2014

News Daily News

Las Variables Ecocardiográficas Predicen el Fracaso de las Intervenciones MitraClip

L.A. McKeown

March 27, 2014

News Daily News

Echocardiographic Variables Predict Failure of MitraClip Procedures

L.A. McKeown

March 27, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

L.A. McKeown

March 20, 2014

News Daily News

La Prueba de la Troponina T de Alta Sensibilidad revela una Sólida Capacidad Pronóstica en pacientes STEMI

L.A. McKeown

March 20, 2014

News Daily News

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

L.A. McKeown

March 20, 2014

News Daily News

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

L.A. McKeown

March 20, 2014

News Daily News

研究质疑TAVR改善心理及总体健康状况的能力

L.A. McKeown

March 13, 2014

News Daily News

Thrombocytopenia Serves as Marker of Short- and Long-term Mortality after TAVR

L.A. McKeown

March 13, 2014

News Daily News

Study Questions Ability of TAVR to Improve Psychological, General Health

L.A. McKeown

March 13, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

L.A. McKeown

March 13, 2014

News Daily News

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

L.A. McKeown

March 13, 2014

News Daily News

La Trombocitopenia Sirve como Marcador de la Mortalidad a Corto y Largo Plazo post-TAVR

L.A. McKeown

March 13, 2014

Advertisement

No Impact on Safety Seen at Hospitals Performing PCI with No Surgical Backup

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

Las Variables Ecocardiográficas Predicen el Fracaso de las Intervenciones MitraClip

Echocardiographic Variables Predict Failure of MitraClip Procedures

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

La Prueba de la Troponina T de Alta Sensibilidad revela una Sólida Capacidad Pronóstica en pacientes STEMI

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

研究质疑TAVR改善心理及总体健康状况的能力

Thrombocytopenia Serves as Marker of Short- and Long-term Mortality after TAVR

Study Questions Ability of TAVR to Improve Psychological, General Health

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

La Trombocitopenia Sirve como Marcador de la Mortalidad a Corto y Largo Plazo post-TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content